Cisatracurium-induced proliferation impairment and death of colorectal cancer cells, HCT116 is mediated by p53 dependent intrinsic apoptotic pathway in vitro
Authors:
- 1 July 2017
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 91, 320-329
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273923)
This publication has 40 references indexed in Scilit:
- Trends in overweight and misperceived overweight in Spain from 1987 to 2007International Journal of Obesity, 2010
- Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer, 2009
- International Trends in Colorectal Cancer Incidence RatesCancer Epidemiology, Biomarkers & Prevention, 2009
- Specific Cleavage of Mcl-1 by Caspase-3 in Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis in Jurkat Leukemia T CellsJournal of Biological Chemistry, 2005
- Cisatracurium, but not mivacurium, induces apoptosis in human umbilical vein endothelial cells in vitroEuropean Journal of Anaesthesiology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Growth Inhibition, Cell-Cycle Dysregulation, and Induction of Apoptosis by Green Tea Constituent (-)-Epigallocatechin-3-gallate in Androgen-Sensitive and Androgen-Insensitive Human Prostate Carcinoma CellsToxicology and Applied Pharmacology, 2000
- Clinical Pharmacokinetics of Cisatracurium BesilateClinical Pharmacokinetics, 1999
- The pharmacodynamics and pharmacokinetics of cisatracurium in patients with renal or hepatic failureCurrent Opinion in Anaesthesiology, 1996
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993